MGMT methylation: a marker of response to temozolomide in low-grade gliomas.
Everhard S, Kaloshi G, Crinière E, Benouaich-Amiel A, Lejeune J, Marie Y, Sanson M, Kujas M, Mokhtari K, Hoang-Xuan K, Delattre JY, Thillet J.
Everhard S, et al. Among authors: delattre jy.
Ann Neurol. 2006 Dec;60(6):740-3. doi: 10.1002/ana.21044.
Ann Neurol. 2006.
PMID: 17192931
Clinical Trial.